Mostrar el registro sencillo del ítem

dc.contributor.authorAngel Rico, Miguel
dc.contributor.authorTrento, Alfonsina 
dc.contributor.authorMelero, Jose Antonio 
dc.contributor.authorRamos, Manuel 
dc.contributor.authorJohnstone, Carolina 
dc.contributor.authorVal, Margarita del 
dc.contributor.authorLopez, Daniel 
dc.date.accessioned2020-07-06T05:53:33Z
dc.date.available2020-07-06T05:53:33Z
dc.date.issued2009
dc.identifier.citationImmunol Cell Biol . May-Jun 2009;87(4):344-50.es_ES
dc.identifier.issn0818-9641es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/10654
dc.description.abstractHuman respiratory syncytial virus (HRSV) is the most common cause of severe respiratory infections in infants and young children, often leading to hospitalization. Although human airway epithelial cells are the main target of HRSV, it has been reported that this virus can also infect professional antigen-presenting cells such as macrophages and dendritic cells, promoting upregulation of maturation markers. Here, we report that mouse spleen B220(+) B lymphocytes were susceptible to HRSV infection in vitro, probably involving a glycosaminoglycan-dependent mechanism. In contrast, neither CD4(+) nor CD8(+) T lymphocytes were infected. In B lymphocytes, HRSV infection upregulated major histocompatibility complex (MHC) class II but not MHC class I molecules and induced the expression of the activation marker CD86.es_ES
dc.description.sponsorshipDr Mark E Peeples (Department of Immunology/Microbiology, Rush‐Presbyterian‐St Luke's Medical Center, Chicago, IL, USA) kindly provided the rgHRSV. Technical assistance of Carmen Mir is gratefully acknowledged. This study was supported by grants from Programa Ramón y Cajal and Fondo de Investigaciones Sanitarias de la Seguridad Social to DL; by grant SAF2006‐07805 from Ministerio de Educación y Ciencia to JAM; by grants from Comunidad de Madrid and SAF‐2004‐00534 from Ministerio de Educación y Ciencia to MDV; and by a joint grant from Instituto de Salud Carlos III to DL, JAM and MDV.es_ES
dc.language.isoenges_ES
dc.publisherWiley es_ES
dc.type.hasVersionAMes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subject.meshAnimals es_ES
dc.subject.meshB-Lymphocytes es_ES
dc.subject.meshBiomarkers es_ES
dc.subject.meshCD4-Positive T-Lymphocytes es_ES
dc.subject.meshCD8-Positive T-Lymphocytes es_ES
dc.subject.meshGlycosaminoglycans es_ES
dc.subject.meshHistocompatibility Antigens Class I es_ES
dc.subject.meshHistocompatibility Antigens Class II es_ES
dc.subject.meshLymphocyte Activation es_ES
dc.subject.meshMice es_ES
dc.subject.meshMice, Inbred C57BL es_ES
dc.subject.meshRespiratory Syncytial Virus Infections es_ES
dc.subject.meshRespiratory Syncytial Virus, Humanes_ES
dc.titleHuman respiratory syncytial virus infects and induces activation markers in mouse B lymphocytes.es_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID19153593es_ES
dc.format.volume87es_ES
dc.format.number4es_ES
dc.format.page344-50es_ES
dc.identifier.doi10.1038/icb.2008.109es_ES
dc.contributor.funderMinisterio de Educación y Ciencia (España) 
dc.contributor.funderComunidad de Madrid (España) 
dc.contributor.funderInstituto de Salud Carlos III 
dc.description.peerreviewedes_ES
dc.relation.publisherversionhttps://doi.org/10.1038/icb.2008.109es_ES
dc.identifier.journalImmunology and cell biologyes_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/SAF2006‐07805es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/SAF‐2004‐00534es_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-CompartirIgual 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución-NoComercial-CompartirIgual 4.0 Internacional